IHM
AZN icon

Iguana Healthcare Management’s AstraZeneca AZN Stock Holding History

Iguana Healthcare Management’s Portfolio AZN Stock Details AZN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q3 		– Sell
-50,000
Closed -$3.41M – 69
2017
Q2 		$3.41M Buy
+50,000
New +$3.27M 1.93% 20

Other funds holding AZN

Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
EIP
Epoch Investment Partners New York $16.5B AUM 24.3% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Iguana Healthcare Management's AZN Position: Q2 2017 in Review

Iguana Healthcare Management sold out of AstraZeneca (AZN) in Q2 2017, closing a stake of 25,000 shares — an estimated $1.63M sold.

Iguana Healthcare Management first reported a position in AZN in Q4 2016 and held it in 2 quarters. The position peaked at $1.56M in Q1 2017. 466 funds tracked by Wall St. Rank hold AZN as of Q2 2017.

  • Iguana Healthcare Management reported no remaining AstraZeneca position as of Q2 2017 after selling out during the quarter.
  • Iguana Healthcare Management sold 25,000 AstraZeneca shares in Q2 2017, an estimated $1.63M.
  • Iguana Healthcare Management first reported a position in AstraZeneca in Q4 2016 and held it in 2 quarters.
  • Iguana Healthcare Management's AstraZeneca position peaked at $1.56M in Q1 2017.
  • 466 funds tracked by Wall St. Rank held AstraZeneca as of Q2 2017.

Based on Iguana Healthcare Management's 13F filing for Q2 2017, filed 14 Aug 2017.